Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($3.10).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Stifel on Eos Energy Enterprises (EOSE) amid 10% gain: 'we view the collaboration with Google as a positive step for EOSE'
• The Harris Agency Opens Applications for the 2027 THA Impact Program
• Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance